ZOLL Medical Corporation Named to Globe 100
20th Annual Listing Ranks Top Massachusetts-Based Public Companies
June 11, 2008—CHELMSFORD, Mass.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that The Boston Globe has named the Company to the “Globe 100” list of top performing public companies in Massachusetts.
Based on a composite score derived from financial data for the four quarters ending December 31, 2007, ZOLL was ranked 43 among Massachusetts-based companies whose stock is publicly traded, moving up from number 52 a year earlier in 2006. It is one of six medical device companies to have been included in the Globe 100.
"These companies represent the resiliency of Massachusetts business, surviving recessions, merger manias, and dramatic shifts in their industries," said Shirley Leung, business editor of the Boston Globe.
To qualify for the Globe 100, a company must have been public for the entire 2007 calendar year and have reported a positive net income for both 2006 and 2007.
"We are honored to be recognized in the company of Massachusetts’ strongest business organizations from various sectors, and delighted that our performance has climbed in ranking despite a turbulent economic climate," said Richard A. Packer, President and Chief Executive Officer of ZOLL.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See Thru CPR™, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com.
About The Boston Globe
The Boston Globe is wholly owned by The New York Times Company (NYSE: NYT), which is a leading media company with 2007 revenues of $3.2 billion, and includes The New York Times, the International Herald Tribune, The Boston Globe, 16 other daily newspapers, WQXR-FM and more than 50 Web sites, including NYTimes.com, Boston.com and About.com. The Globe’s core purpose is to enhance society by creating, collecting and distributing high-quality news, information and entertainment.
Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the SEC on May 9, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.
Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, Real CPR Help and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All names are the property of their respective owners.